| Samantha Kohnen, AUD | |
|
1630 101st Ave Ne Ste 160, Blaine, MN 55449-3403 | |
| (618) 301-0407 | |
| Not Available |
| Full Name | Samantha Kohnen |
|---|---|
| Gender | Female |
| Speciality | Qualified Audiologist |
| Experience | 4 Years |
| Location | 1630 101st Ave Ne Ste 160, Blaine, Minnesota |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1598349797 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 231H00000X | Audiologist | 10361 (Minnesota) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Ear Nose And Throat Specialty Care Of Minnesota Pa | 3274524020 | 38 |
News Archive
National Institutes of Health (NIH) Director Francis S. Collins, M.D., Ph.D., will lead a briefing on Capitol Hill Thursday, May 20, to discuss how funding for medical research at the NIH can be used more quickly to create new therapies for patients and save lives.
The Stowers Institute for Medical Research is pleased to announce the formation of its graduate program: The Graduate School of the Stowers Institute for Medical Research.
Celgene International Sàrl announced that REVLIMID (lenalidomide) has been granted full marketing authorization by Japan's Ministry of Health, Labour and Welfare (MHLW) for the treatment of patients with myelodysplastic syndromes (MDS) associated with a deletion 5q cytogenic abnormality. REVLIMID was also approved in June 2010 in combination with dexamethasone, for the treatment of patients with relapsed or refractory multiple myeloma who have received at least one prior standard therapy.
Researchers at New York University and Israel's Weizmann Institute of Science have identified patterns of brain activation linked to the formation of long-term memories.
Understanding the tricks and survival strategies of viruses to effectively combat them: That is the goal of the virtual institute VISTRIE that received its funding commitment today.
› Verified 7 days ago
| Provider Name | National Dizzy & Balance Center,ltd. |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1023021938 PECOS PAC ID: 7315983954 Enrollment ID: O20050705000689 |
News Archive
National Institutes of Health (NIH) Director Francis S. Collins, M.D., Ph.D., will lead a briefing on Capitol Hill Thursday, May 20, to discuss how funding for medical research at the NIH can be used more quickly to create new therapies for patients and save lives.
The Stowers Institute for Medical Research is pleased to announce the formation of its graduate program: The Graduate School of the Stowers Institute for Medical Research.
Celgene International Sàrl announced that REVLIMID (lenalidomide) has been granted full marketing authorization by Japan's Ministry of Health, Labour and Welfare (MHLW) for the treatment of patients with myelodysplastic syndromes (MDS) associated with a deletion 5q cytogenic abnormality. REVLIMID was also approved in June 2010 in combination with dexamethasone, for the treatment of patients with relapsed or refractory multiple myeloma who have received at least one prior standard therapy.
Researchers at New York University and Israel's Weizmann Institute of Science have identified patterns of brain activation linked to the formation of long-term memories.
Understanding the tricks and survival strategies of viruses to effectively combat them: That is the goal of the virtual institute VISTRIE that received its funding commitment today.
› Verified 7 days ago
| Provider Name | Ear Nose & Throat Specialty Care Of Minnesota Pa |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1336175744 PECOS PAC ID: 3274524020 Enrollment ID: O20051116000590 |
News Archive
National Institutes of Health (NIH) Director Francis S. Collins, M.D., Ph.D., will lead a briefing on Capitol Hill Thursday, May 20, to discuss how funding for medical research at the NIH can be used more quickly to create new therapies for patients and save lives.
The Stowers Institute for Medical Research is pleased to announce the formation of its graduate program: The Graduate School of the Stowers Institute for Medical Research.
Celgene International Sàrl announced that REVLIMID (lenalidomide) has been granted full marketing authorization by Japan's Ministry of Health, Labour and Welfare (MHLW) for the treatment of patients with myelodysplastic syndromes (MDS) associated with a deletion 5q cytogenic abnormality. REVLIMID was also approved in June 2010 in combination with dexamethasone, for the treatment of patients with relapsed or refractory multiple myeloma who have received at least one prior standard therapy.
Researchers at New York University and Israel's Weizmann Institute of Science have identified patterns of brain activation linked to the formation of long-term memories.
Understanding the tricks and survival strategies of viruses to effectively combat them: That is the goal of the virtual institute VISTRIE that received its funding commitment today.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Samantha Kohnen, AUD 4801 W 81st St Ste 112, Bloomington, MN 55437-1111 Ph: (952) 345-3000 | Samantha Kohnen, AUD 1630 101st Ave Ne Ste 160, Blaine, MN 55449-3403 Ph: (618) 301-0407 |
News Archive
National Institutes of Health (NIH) Director Francis S. Collins, M.D., Ph.D., will lead a briefing on Capitol Hill Thursday, May 20, to discuss how funding for medical research at the NIH can be used more quickly to create new therapies for patients and save lives.
The Stowers Institute for Medical Research is pleased to announce the formation of its graduate program: The Graduate School of the Stowers Institute for Medical Research.
Celgene International Sàrl announced that REVLIMID (lenalidomide) has been granted full marketing authorization by Japan's Ministry of Health, Labour and Welfare (MHLW) for the treatment of patients with myelodysplastic syndromes (MDS) associated with a deletion 5q cytogenic abnormality. REVLIMID was also approved in June 2010 in combination with dexamethasone, for the treatment of patients with relapsed or refractory multiple myeloma who have received at least one prior standard therapy.
Researchers at New York University and Israel's Weizmann Institute of Science have identified patterns of brain activation linked to the formation of long-term memories.
Understanding the tricks and survival strategies of viruses to effectively combat them: That is the goal of the virtual institute VISTRIE that received its funding commitment today.
› Verified 7 days ago
Dr. Sarah O Binfet, AU.D Audiologist Medicare: Accepting Medicare Assignments Practice Location: 10995 Club West Pkwy Ste 100, Blaine, MN 55449 Phone: 763-717-0072 Fax: 763-717-0074 | |
Blaine Audiology & Hearing Center Llc Audiologist Medicare: Not Enrolled in Medicare Practice Location: 10995 Club West Pkwy Ste 100, Blaine, MN 55449 Phone: 952-922-2408 | |
Karen Janssen, AUD Audiologist Medicare: Medicare Enrolled Practice Location: 1630 101st Ave Ne Ste 160, Blaine, MN 55449 Phone: 952-345-3000 Fax: 952-345-6789 |